GSK plc 6-K, filed Nov 25, 2022
GSK plc (GSK)
6-K
2022-11-25
For: 2022-11-25
View Original
Added on
April 10, 2026
About this 6-K
GSK plc filed this 6-K on November 25, 2022.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of November 2022
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ____
GSK plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for
2023:
|
Results
|
Announcement date
|
Ex-dividend date
|
Record date
|
Last date for DRIP elections
|
Payable
|
|
Q1 2023
|
Wednesday
26 April 2023
|
Thursday
18 May 2023
|
Friday
19 May 2023
|
Wednesday
21 June 2023
|
Thursday
13 July 2023
|
|
Q2 2023
|
Wednesday
26 July 2023
|
Thursday
17 August 2023
|
Friday
18 August 2023
|
Wednesday
20 September 2023
|
Thursday
12 October 2023
|
|
Q3 2023
|
Wednesday
1 November 2023
|
Thursday
16 November 2023
|
Friday
17 November 2023
|
Monday
18 December 2023
|
Thursday
11 January 2024
|
|
Q4 2023
(Final)
|
Wednesday
31 January 2024
|
Thursday
22 February 2024
|
Friday
23 February 2024
|
Tuesday
19 March 2024
|
Thursday
11 April 2024
|
These dates are indicative and may be subject to
change.
V A Whyte
Company Secretary
24 November 2022
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GSK plc
|
|
|
(Registrant)
|
|
|
|
|
Date: November
24, 2022
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|